Texas vs Colorado Cannabis Laws

Texas has one of the most restrictive medical cannabis programs in the country. The Texas Compassionate Use Act, signed in 2015, created the Compassionate Use Program (CUP), initially limited to patients with intractable epilepsy and restricted to low-THC cannabis products. HB 1535, passed in 2021, expanded the program to include additional qualifying conditions such as cancer, PTSD, and certain neurodegenerative diseases, and raised the THC cap from 0.5% to 1%. Despite these expansions, the program remains far more limited than standard medical cannabis programs in other states.

The Texas market structure is extraordinarily restrictive. Only 3 vertically integrated dispensing organizations are licensed to operate statewide, serving a population of approximately 30 million people. This creates significant access challenges for patients, as the limited number of dispensary locations cannot adequately serve the state's vast geography. Products are limited to low-THC cannabis preparations, and the 1% THC cap means patients cannot access the full-potency products available in most medical states.

Despite being the second most populous state, Texas generates modest cannabis revenue estimated at roughly $50 million annually from its CUP program. The extremely limited license structure, low THC cap, and restricted qualifying conditions severely constrain the market. No major MSOs currently operate in Texas, as the 3 existing licenses are held by local operators. If Texas were to significantly expand its medical program or legalize recreational cannabis, it would instantly become one of the largest cannabis markets in the world. Market analysts estimate a fully legalized Texas market could generate $3-5 billion in annual sales, making it a closely watched state for potential reform.

Colorado holds a pioneering place in American cannabis history. In 2012, Amendment 64 made Colorado and Washington the first two states to legalize recreational cannabis. Medical cannabis had already been legal since Amendment 20 passed in 2000. The first recreational dispensaries opened on January 1, 2014, launching what would become one of the most established cannabis markets in the country.

The Colorado market matured rapidly, surpassing $2 billion in annual sales at its peak before settling closer to $1.8 billion as competition increased from newly legalized neighboring states. The market has experienced significant price compression, with wholesale flower prices declining substantially. Despite these headwinds, Colorado remains an important market due to its regulatory stability and experienced workforce.

Colorado's tax structure includes a 15% excise tax at first transfer and a 15% special state sales tax on retail purchases, in addition to the standard 2.9% state sales tax. Local municipalities may add their own taxes. Major MSOs including Curaleaf, Green Thumb Industries, Cresco Labs, Trulieve, and Columbia Care operate in the state, though the market also features a strong independent operator ecosystem. Colorado continues to serve as a model for cannabis regulation nationwide.